US Dollar vs MXN

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
NASDAQ
Poniard Pharmaceuticals, Inc. (MM) (PARD)
Poniard Pharmaceuticals, Inc. (MM) (PARD) Noticias

PARD

Poniard Pharmaceuticals, Inc. (MM) (PARD)

Poniard Pharmaceuticals, Inc. (MM)

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PARD

1 2 3 4 5 6 7 8 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
03/01/2012	07:00	Marketwired	Poniard Pharmaceuticals Common Stock to Be Delisted From Nasdaq Stock Market, Intention to List on OTC Bulletin Board	NASDAQ:PARD	Poniard Pharmaceuticals, Inc. (MM)
23/12/2011	14:37	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:PARD	Poniard Pharmaceuticals, Inc. (MM)
21/11/2011	12:15	Marketwired	Poniard Pharmaceuticals Announces Shareholders Approve Merger With ALLOZYNE	NASDAQ:PARD	Poniard Pharmaceuticals, Inc. (MM)
21/11/2011	08:00	Marketwired	Steps in the Right Direction - Featured Research on Poniard Pharmaceuticals, Inc. and Gilead Sciences, Inc.	NASDAQ:PARD	Poniard Pharmaceuticals, Inc. (MM)
18/11/2011	12:00	Edgar (US Regulatory)	Filing of certain prospectuses and communications in connection with business combination transactions (425)	NASDAQ:PARD	Poniard Pharmaceuticals, Inc. (MM)
18/11/2011	07:30	Marketwired	Poniard Pharmaceuticals Announces Licensing Agreement for Focal Adhesion Kinase Technology	NASDAQ:PARD	Poniard Pharmaceuticals, Inc. (MM)
09/11/2011	07:30	Marketwired	ISS Proxy Advisory Services Recommends Poniard Shareholders Vote "FOR" Poniard's Proposed Merger With ALLOZYNE and Reverse St...	NASDAQ:PARD	Poniard Pharmaceuticals, Inc. (MM)
07/11/2011	07:30	Marketwired	Glass Lewis Recommends Poniard Shareholders Vote "FOR" Poniard's Proposed Merger With ALLOZYNE and Reverse Stock Split	NASDAQ:PARD	Poniard Pharmaceuticals, Inc. (MM)
04/11/2011	05:10	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(3) (424B3)	NASDAQ:PARD	Poniard Pharmaceuticals, Inc. (MM)
28/10/2011	15:01	Marketwired	Poniard Pharmaceuticals Reports Third Quarter 2011 Financial Results	NASDAQ:PARD	Poniard Pharmaceuticals, Inc. (MM)
28/10/2011	12:59	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:PARD	Poniard Pharmaceuticals, Inc. (MM)
28/10/2011	07:30	Marketwired	Egan-Jones Recommends Poniard Shareholders Vote "FOR" Poniard's Proposed Merger With ALLOZYNE and Reverse Stock Split	NASDAQ:PARD	Poniard Pharmaceuticals, Inc. (MM)
21/10/2011	13:00	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NASDAQ:PARD	Poniard Pharmaceuticals, Inc. (MM)
11/10/2011	08:10	Dow Jones News	Registration Effectiveness Orders Issued By The SEC	NASDAQ:PARD	Poniard Pharmaceuticals, Inc. (MM)
11/10/2011	05:00	Edgar (US Regulatory)	Notice of Effectiveness (EFFECT)	NASDAQ:PARD	Poniard Pharmaceuticals, Inc. (MM)
07/10/2011	16:43	Marketwired	Poniard Pharmaceuticals Announces Effectiveness of Form S-4 Registration Statement for the Proposed Merger with ALLOZYNE	NASDAQ:PARD	Poniard Pharmaceuticals, Inc. (MM)
07/10/2011	16:27	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PARD	Poniard Pharmaceuticals, Inc. (MM)
07/10/2011	12:22	Edgar (US Regulatory)	Confidential Treatment Order (CT ORDER)	NASDAQ:PARD	Poniard Pharmaceuticals, Inc. (MM)
06/10/2011	11:33	Edgar (US Regulatory)	Registration Statement for securities to be issued in business combination transactions (S-4/A)	NASDAQ:PARD	Poniard Pharmaceuticals, Inc. (MM)
06/09/2011	07:39	Marketwired	Poniard Pharmaceuticals Receives Favorable NASDAQ Decision for Continued Listing of Company Shares	NASDAQ:PARD	Poniard Pharmaceuticals, Inc. (MM)
12/08/2011	15:01	Marketwired	Poniard Pharmaceuticals Reports Second Quarter 2011 Financial Results	NASDAQ:PARD	Poniard Pharmaceuticals, Inc. (MM)
25/07/2011	16:38	Marketwired	Poniard Pharmaceuticals Announces Filing of Form S-4 Registration Statement Related to Proposed Merger With ALLOZYNE	NASDAQ:PARD	Poniard Pharmaceuticals, Inc. (MM)
25/07/2011	16:22	Edgar (US Regulatory)	Securities Registration: Business Combination (S-4)	NASDAQ:PARD	Poniard Pharmaceuticals, Inc. (MM)
11/07/2011	10:49	Marketwired	Poniard Pharmaceuticals Adjourns Reconvened Annual Meeting of Shareholders to Solicit Additional Proxies for Important Reverse S	NASDAQ:PARD	Poniard Pharmaceuticals, Inc. (MM)
07/07/2011	18:09	Business Wire	The Law Firm of Levi & Korsinsky, LLP Announces Investigation of Poniard Pharmaceuticals, Inc.	NASDAQ:PARD	Poniard Pharmaceuticals, Inc. (MM)
05/07/2011	07:30	Marketwired	Poniard Pharmaceuticals Announces Intention to Adjourn Annual Meeting of Shareholders to Solicit Additional Proxies for Importan	NASDAQ:PARD	Poniard Pharmaceuticals, Inc. (MM)
05/07/2011	05:03	Edgar (US Regulatory)	Statement of Beneficial Ownership (SC 13D)	NASDAQ:PARD	Poniard Pharmaceuticals, Inc. (MM)
22/06/2011	18:06	Business Wire	Law Office of Brodsky & Smith, LLC Announces Investigation of Poniard Pharmaceuticals, Inc.	NASDAQ:PARD	Poniard Pharmaceuticals, Inc. (MM)
22/06/2011	15:26	Marketwired	Poniard Pharmaceuticals and ALLOZYNE Sign Definitive Merger Agreement	NASDAQ:PARD	Poniard Pharmaceuticals, Inc. (MM)
09/06/2011	12:31	Marketwired	Poniard Pharmaceuticals Adjourns Annual Meeting of Shareholders	NASDAQ:PARD	Poniard Pharmaceuticals, Inc. (MM)

Showing the most relevant articles for your search:NASDAQ:PARD

1 2 3 4 5 6 7 8 Próxima >

American Express

Invesco QQQ Trust Series 1

Bank of America

Verizon Communications

JP Morgan Chase

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones